These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 21036004

  • 1. [Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack].
    Velayoudom-Cephise FL, Foucan L, Soudan B, Cardot-Bauters C, Vantyghem MC, D'herbomez M, Tison-Muchery F, Wemeau JL.
    Presse Med; 2011 Feb; 40(2):e120-7. PubMed ID: 21036004
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Silverberg SJ.
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [Abstract] [Full Text] [Related]

  • 3. Primary hyperparathyroidism and the skeleton.
    Mosekilde L.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [Abstract] [Full Text] [Related]

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jul; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 5. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Bilezikian JP, Silverberg SJ.
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [Abstract] [Full Text] [Related]

  • 7. The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.
    Raef H, Ingemansson S, Sobhi S, Sultan A, Ahmed M, Chaudhry M.
    J Endocrinol Invest; 2004 Oct; 27(9):807-12. PubMed ID: 15648543
    [Abstract] [Full Text] [Related]

  • 8. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
    Walker MD, Saeed I, Lee JA, Zhang C, Hans D, Lang T, Silverberg SJ.
    Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
    [Abstract] [Full Text] [Related]

  • 9. Primary hyperparathyroidism and vitamin D deficiency.
    Vélayoudom-Céphise FL, Wémeau JL.
    Ann Endocrinol (Paris); 2015 May; 76(2):153-62. PubMed ID: 25916759
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D and primary hyperparathyroidism (PHPT).
    Souberbielle JC, Bienaimé F, Cavalier E, Cormier C.
    Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
    [Abstract] [Full Text] [Related]

  • 11. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
    Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C.
    Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D status in primary hyperparathyroidism: a Southern European perspective.
    Tassone F, Gianotti L, Baffoni C, Visconti G, Pellegrino M, Cassibba S, Croce CG, Magro G, Cesario F, Attanasio R, Borretta G.
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):784-90. PubMed ID: 23521111
    [Abstract] [Full Text] [Related]

  • 13. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
    Shah VN, Shah CS, Bhadada SK, Rao DS.
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of primary hyperparathyroidism among patients with low bone mass.
    Misiorowski W, Zgliczyński W.
    Adv Med Sci; 2012 Jun; 57(2):308-13. PubMed ID: 23314564
    [Abstract] [Full Text] [Related]

  • 15. Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.
    Cong E, Walker MD, Kepley A, Zhang C, McMahon DJ, Silverberg SJ.
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3452-9. PubMed ID: 26120793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
    Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.